IGF1 and amyotrophic lateral sclerosis: Neurotrophic growth factors that play key roles in the survival of motor neurons, including IGF-1, vascular endothelial growth factor (VEGF), GDNF, and granulocyte-colony stimulating factor (G-CSF), have been considered for ALS therapies (Hester et al., 2009).